Jacobus Wealth Management’s Elevance Health ELV Stock Holding History

Jacobus Wealth Management’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-1,442	Closed	-$200K	–	232
2016 Q1	$200K	Buy	1,442 +225	+18%	+$30.1K	0.06%	199
2015 Q4	$170K	Hold	1,217	–	–	0.05%	217
2015 Q3	$170K	Sell	1,217 -255	-17%	-$38.3K	0.05%	222
2015 Q2	$242K	Sell	1,472 -440	-23%	-$70.3K	0.06%	200
2015 Q1	$295K	Buy	1,912 +542	+40%	+$77.2K	0.08%	175
2014 Q4	$172K	Buy	1,370 +390	+40%	+$48.2K	0.04%	221
2014 Q3	$117K	Hold	980	–	–	0.03%	270
2014 Q2	$105K	Buy	+980	New	+$101K	0.03%	305

Other funds holding ELV

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

Jacobus Wealth Management's ELV Position: Q2 2016 in Review

Jacobus Wealth Management sold out of Elevance Health (ELV) in Q2 2016, closing a stake of 1,442 shares — an estimated $200K sold.

Jacobus Wealth Management first reported a position in ELV in Q2 2014 and held it in 8 quarters. The position peaked at $295K in Q1 2015. 759 funds tracked by Wall St. Rank hold ELV as of Q2 2016.

Jacobus Wealth Management reported no remaining Elevance Health position as of Q2 2016 after selling out during the quarter.
Jacobus Wealth Management sold 1,442 Elevance Health shares in Q2 2016, an estimated $200K.
Jacobus Wealth Management first reported a position in Elevance Health in Q2 2014 and held it in 8 quarters.
Jacobus Wealth Management's Elevance Health position peaked at $295K in Q1 2015.
759 funds tracked by Wall St. Rank held Elevance Health as of Q2 2016.

Based on Jacobus Wealth Management's 13F filing for Q2 2016, filed 5 Aug 2016.